Ligand validation:4IRE

PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PC1 is a Ligand Of Interest in 4IRE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IRE_PC1_B_402	4%	42%	0.436	0.858	1.16	1.08	6	5	0	0	70%	0.7037
4IRE_PC1_A_403	3%	36%	0.443	0.809	1.19	1.31	6	7	2	0	72%	0.7222
4IRE_PC1_D_503	2%	41%	0.383	0.75	1.21	1.08	6	3	1	0	69%	0.6852
4IRE_PC1_B_401	2%	41%	0.421	0.764	1.15	1.16	7	4	2	0	72%	0.7222
4IRE_PC1_C_403	2%	40%	0.444	0.747	1.15	1.18	7	4	0	0	70%	0.7037
4IRE_PC1_E_405	2%	42%	0.426	0.723	1.16	1.11	7	4	1	0	70%	0.7037
4IRE_PC1_D_502	1%	39%	0.448	0.74	1.14	1.22	7	2	3	0	69%	0.6852
4IRE_PC1_E_406	1%	39%	0.547	0.76	1.16	1.21	7	5	0	0	70%	0.7037
4IRE_PC1_A_402	1%	39%	0.552	0.724	1.21	1.16	7	3	0	0	69%	0.6852
4IRE_PC1_C_404	1%	35%	0.511	0.666	1.24	1.33	6	2	0	0	59%	0.5926
3EAM_PC1_E_601	25%	24%	0.202	0.863	1.43	1.69	4	6	0	1	87%	0.8704
5IUX_PC1_E_405	14%	39%	0.159	0.756	1.32	1.07	5	1	0	0	72%	0.7222
4F8H_PC1_A_403	8%	42%	0.323	0.861	1.16	1.1	6	4	0	0	69%	0.6852
3WGU_PC1_A_2011	62%	45%	0.128	0.919	0.92	1.21	4	5	3	0	100%	1
3WGV_PC1_A_2011	51%	42%	0.141	0.893	0.94	1.32	4	6	1	0	100%	1
3AYN_PC1_B_1004	42%	35%	0.116	0.885	1.62	0.98	3	1	1	0	72%	0.7222
2Z73_PC1_B_1004	29%	34%	0.182	0.889	1.64	0.97	2	1	1	0	72%	0.7222
1BP1_PC1_A_777	22%	52%	0.246	0.864	1.06	0.79	2	2	10	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.